| |
| | | In The Rise of Genetic Testing in Healthcare Report, Insider Intelligence will examine the industry forces that have helped evolve genomic information from a consumer novelty to a transformative healthcare technology. We outline how some of the key players in the genetic testing space have altered their business models to appeal not only to consumers but also healthcare players across the industry, including health systems and pharma companies. We provide a glimpse at what's next for the implementation of genomic information — namely, the barriers that are holding genetic testing companies back from reaching new customers, including how the coronavirus pandemic could impact growth in the space. | In full, this exclusive report: |
|
|
| 1 | Provides an overview of the ways in which prominent US genetic testing companies are using their products to edge deeper into the healthcare landscape | | 2 | Highlights how leading telehealth vendors have reacted to a sudden, rapid uptick in adoption of their services | | 3 | Outlines how legacy healthcare players — including health systems, payers, and drug-makers — are leveraging genetic testing companies' products to make use of insights into genetic variants | | 4 | Identifies the barriers that genetic companies are staring down that could hinder growth and adoption |
|
|
|
| |
| |
| |
